Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience

Introduction. Hepatitis C virus (HCV) infection is an independent risk factor for renal transplantation (RTx). Immunosuppression minimization can render better quality of life to these patients. Methods. We analyzed 132 HCV-positive RTx patients (group A) transplanted under tolerance induction proto...

Full description

Saved in:
Bibliographic Details
Main Authors: P. R. Shah, A. V. Vanikar, M. R. Gumber, H. V. Patel, V. B. Kute, S. M. Godara, H. L. Trivedi
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2011/581485
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560011746738176
author P. R. Shah
A. V. Vanikar
M. R. Gumber
H. V. Patel
V. B. Kute
S. M. Godara
H. L. Trivedi
author_facet P. R. Shah
A. V. Vanikar
M. R. Gumber
H. V. Patel
V. B. Kute
S. M. Godara
H. L. Trivedi
author_sort P. R. Shah
collection DOAJ
description Introduction. Hepatitis C virus (HCV) infection is an independent risk factor for renal transplantation (RTx). Immunosuppression minimization can render better quality of life to these patients. Methods. We analyzed 132 HCV-positive RTx patients (group A) transplanted under tolerance induction protocol (TIP) and compared them with 79 controls (group B) transplanted using standard triple drugs. TIP consisted of 1 donor-specific transfusion, peripheral blood stem cell infusion, portal infusion of bone marrow, and target-specific irradiation. Their immunosuppression was cyclosporin, 2 ± 1 mg/kg BW/day + prednisone, 10 mg/day. Results. TIP had no side effects. Although unequal in size, the groups were well balanced. Group A patient survival at 1, 5, and 10 years was 92.4%, 70.4%, and 63.7%, respectively, versus 75.6%, 71.7%, and 55.7% in later, and graft survival was 92.9%, 81.5%, and 79.1% versus 91.7%, 75.7%, and 67.7%, respectively. Mean serum creatinine (mg/dL) at these time periods in former was 1.38, 1.72, and 1.87, versus 1.3, 1.75, and 2.1 in later. Altered liver functions were noted in 22% patients in former versus 31% in later. Group A had lesser rejection episodes. Conclusion. RTx using TIP in HCV-positive patients is a viable option with acceptable outcome.
format Article
id doaj-art-f714d04e4fcc441fb9d51171dd1acb72
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-f714d04e4fcc441fb9d51171dd1acb722025-02-03T01:28:40ZengWileyJournal of Transplantation2090-00072090-00152011-01-01201110.1155/2011/581485581485Renal Transplantation in Hepatitis C Positive Patients: A Single Centre ExperienceP. R. Shah0A. V. Vanikar1M. R. Gumber2H. V. Patel3V. B. Kute4S. M. Godara5H. L. Trivedi6Department of Nephrology and Transplantation Medicine, IKDRC-ITS, Ahmedabad 380016, IndiaDepartment of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, IKDRC-ITS, Ahmedabad 380016, IndiaDepartment of Nephrology and Transplantation Medicine, IKDRC-ITS, Ahmedabad 380016, IndiaDepartment of Nephrology and Transplantation Medicine, IKDRC-ITS, Ahmedabad 380016, IndiaDepartment of Nephrology and Transplantation Medicine, IKDRC-ITS, Ahmedabad 380016, IndiaDepartment of Nephrology and Transplantation Medicine, IKDRC-ITS, Ahmedabad 380016, IndiaDepartment of Nephrology and Transplantation Medicine, IKDRC-ITS, Ahmedabad 380016, IndiaIntroduction. Hepatitis C virus (HCV) infection is an independent risk factor for renal transplantation (RTx). Immunosuppression minimization can render better quality of life to these patients. Methods. We analyzed 132 HCV-positive RTx patients (group A) transplanted under tolerance induction protocol (TIP) and compared them with 79 controls (group B) transplanted using standard triple drugs. TIP consisted of 1 donor-specific transfusion, peripheral blood stem cell infusion, portal infusion of bone marrow, and target-specific irradiation. Their immunosuppression was cyclosporin, 2 ± 1 mg/kg BW/day + prednisone, 10 mg/day. Results. TIP had no side effects. Although unequal in size, the groups were well balanced. Group A patient survival at 1, 5, and 10 years was 92.4%, 70.4%, and 63.7%, respectively, versus 75.6%, 71.7%, and 55.7% in later, and graft survival was 92.9%, 81.5%, and 79.1% versus 91.7%, 75.7%, and 67.7%, respectively. Mean serum creatinine (mg/dL) at these time periods in former was 1.38, 1.72, and 1.87, versus 1.3, 1.75, and 2.1 in later. Altered liver functions were noted in 22% patients in former versus 31% in later. Group A had lesser rejection episodes. Conclusion. RTx using TIP in HCV-positive patients is a viable option with acceptable outcome.http://dx.doi.org/10.1155/2011/581485
spellingShingle P. R. Shah
A. V. Vanikar
M. R. Gumber
H. V. Patel
V. B. Kute
S. M. Godara
H. L. Trivedi
Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience
Journal of Transplantation
title Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience
title_full Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience
title_fullStr Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience
title_full_unstemmed Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience
title_short Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience
title_sort renal transplantation in hepatitis c positive patients a single centre experience
url http://dx.doi.org/10.1155/2011/581485
work_keys_str_mv AT prshah renaltransplantationinhepatitiscpositivepatientsasinglecentreexperience
AT avvanikar renaltransplantationinhepatitiscpositivepatientsasinglecentreexperience
AT mrgumber renaltransplantationinhepatitiscpositivepatientsasinglecentreexperience
AT hvpatel renaltransplantationinhepatitiscpositivepatientsasinglecentreexperience
AT vbkute renaltransplantationinhepatitiscpositivepatientsasinglecentreexperience
AT smgodara renaltransplantationinhepatitiscpositivepatientsasinglecentreexperience
AT hltrivedi renaltransplantationinhepatitiscpositivepatientsasinglecentreexperience